|
|
| ECZ4041 | Pharmaceutical Technology - III | 3+0+0 | ECTS:3 | | Year / Semester | Fall Semester | | Level of Course | Second Cycle | | Status | Compulsory | | Department | DEPARTMENT of PHARMACEUTICS | | Prerequisites and co-requisites | None | | Mode of Delivery | | | Contact Hours | 14 weeks - 3 hours of lectures per week | | Lecturer | Arş. Gör. Hatice DEMİRTAŞ | | Co-Lecturer | Seçkin ENGİN | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | |
It is aimed to teach the formulation and production of solid drug forms, targeted drug forms, controlled release and new drug carrier systems, biotechnological products and nano-drug carrier systems. |
| Learning Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | LO - 1 : | gains knowledge about the formulations and production technology of solid drug dosage forms. | 1 - 5 - 9 - 14 | 1, | | LO - 2 : | gains knowledge about the formulations and production of targeted drug forms. | 1 - 5 - 9 - 14 | 1, | | LO - 3 : | gains knowledge about the formulations and production of controlled release and new drug carrier systems. | 1 - 5 - 9 - 14 | 1,2,4,5,6, | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), LO : Learning Outcome | | |
| It includes solid drug forms, veterinary drug forms, oral, parenteral, vaginal, rectal and nasal controlled release systems, targeted drug forms, pharmaceutical biotechnology, peptide and protein formulations and nano-drug carrier systems. |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | Micromeritic, Powder Technology | | | Week 2 | Granules - Capsules | | | Week 3 | Tablet Technology | | | Week 4 | Tablet Technology | | | Week 5 | Controlled Release Systems/nanoparticles-Entry and kinetics, Polymers | | | Week 6 | Micro, nano-particulate systems, Solid lipid particles, Vesicular systems | | | Week 7 | Micro, nano-particulate systems, Solid lipid particles, Vesicular systems | | | Week 8 | Nasal systems, Pulmonary systems | | | Week 9 | Midterm exam | | | Week 10 | | | | Week 11 | Ocular systems, Transdermal systems
| | | Week 12 | Vaginal-rectal systems, Mucosal adhesive systems | | | Week 13 | Implanted systems Release systems in the veterinary field | | | Week 14 | Nano carrier systems (liposome, niosome, nanocrystalline micelle, dendrimer, etc.) | | | Week 15 | Nano carrier systems (liposome, niosome, nanocrystalline micelle, dendrimer, etc.) | | | Week 16 | Final exam | | | |
| 1 | Gürsoy, A. Kontrollü Salım Sistemleri | | | 2 | Gürsoy, A. Nanofarmasötikler ve Uygulamaları | | | 3 | Gibson, M. Pharmaceutical Preformulation and Formulation, 2004 | | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 9 | Kasım 2024 | 2 | 50 | | End-of-term exam | 16 | Ocak 2025 | 2 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Yüz yüze eğitim | 3 | 14 | 42 | | Arasınav için hazırlık | 3 | 8 | 24 | | Arasınav | 2 | 1 | 2 | | Dönem sonu sınavı için hazırlık | 3 | 6 | 18 | | Dönem sonu sınavı | 2 | 1 | 2 | | Total work load | | | 88 |
|